Pleiotropic functions of plasminogen activator inhibitor-1
Top Cited Papers
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (1) , 35-45
- https://doi.org/10.1111/j.1538-7836.2004.00827.x
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1: novel tumor-derived factors with a high prognostic and predictive impact in breast cancerThrombosis and Haemostasis, 2004
- Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasisThrombosis and Haemostasis, 2004
- The structural basis for the pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of potential PAI-1 inhibitorsThrombosis and Haemostasis, 2004
- Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor βThe FASEB Journal, 2003
- Plasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue AccumulationArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Biochemical importance of glycosylation of plasminogen activator inhibitor-1Thrombosis and Haemostasis, 2003
- Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.Journal of Clinical Investigation, 1996
- Plasminogen Activator Expression in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Structural basis of latency in plasminogen activator inhibitor-1Nature, 1992
- A critical review of the relationship between impaired fibrinolysis and myocardial infarctionAmerican Heart Journal, 1991